• For Individuals
  • For Institutions
  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
LB Café
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov7
C4 Therapeutics released FY2025 9 Months Earnings on November 6, 2025 EST, with actual revenue of USD 24.93 M and EPS of USD -1.1813
04:00
C4 Therapeutics released FY2025 Q3 earnings on November 6, 2025 (EST), with actual revenue of USD 11.23 M (forecast USD 6.28 M) and actual EPS of USD -0.4432 (forecast USD -0.4086)
04:00
Oct16
C4 Therapeutics Announces Phase 1 Trial Data for Cemsidomide
10:37
Oct1
C4 Therapeutics demonstrates cemsidomide clinical trial progress
14:09
Aug8
C4 Therapeutics released FY2025 Semi-Annual Earnings on August 7 (EST), actual revenue USD 13.7 M, actual EPS USD -0.738
03:00
C4 Therapeutics released FY2025 Q2 earnings on August 7 (EST), actual revenue USD 6.463 M (forecast USD 6.55 M), actual EPS USD -0.37 (forecast USD -0.3925)
03:00

Schedules & Filings

Schedules
Filings
Nov6
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 11.23 M, Net Income -32.17 M, EPS -0.4432

Aug7
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 6.463 M, Net Income -26.02 M, EPS -0.3664

May7
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 7.238 M, Net Income -26.32 M, EPS -0.3716

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
SMX
430.690
+205.45%
+289.690
GURE
9.827
+107.32%
+5.180
TGL
13.830
+104.65%
+7.072
WHLR
6.550
+102.16%
+3.320
TDIC
0.4050
+44.23%
+0.124
IRBT
4.258
+40.53%
+1.240
PRAX
254.900
+34.18%
+64.930
DBRG
12.835
+32.05%
+3.110
YYAI
1.360
+30.74%
+0.320
CHPT
10.917
+28.14%
+2.395
View More